PANICHELLA, GIORGIA
 Distribuzione geografica
Continente #
EU - Europa 2.050
AS - Asia 1.025
NA - Nord America 802
SA - Sud America 188
AF - Africa 22
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.091
Nazione #
IT - Italia 745
US - Stati Uniti d'America 726
RU - Federazione Russa 687
SG - Singapore 571
CN - Cina 181
BR - Brasile 171
IE - Irlanda 147
DE - Germania 123
NL - Olanda 95
HK - Hong Kong 90
GB - Regno Unito 75
CA - Canada 56
FI - Finlandia 44
FR - Francia 44
TR - Turchia 34
IN - India 31
PK - Pakistan 26
BD - Bangladesh 23
AT - Austria 22
MX - Messico 13
VN - Vietnam 13
CH - Svizzera 11
PL - Polonia 11
ZA - Sudafrica 10
IQ - Iraq 9
ES - Italia 8
AR - Argentina 7
BE - Belgio 7
SE - Svezia 7
JP - Giappone 6
UA - Ucraina 6
ID - Indonesia 5
LT - Lituania 5
RO - Romania 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
KR - Corea 4
CZ - Repubblica Ceca 3
KE - Kenya 3
MA - Marocco 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AU - Australia 2
CL - Cile 2
EC - Ecuador 2
EG - Egitto 2
IL - Israele 2
IR - Iran 2
NI - Nicaragua 2
OM - Oman 2
PE - Perù 2
TN - Tunisia 2
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KI - Kiribati 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 4.091
Città #
Singapore 323
Dublin 147
Beijing 122
Hong Kong 86
Milan 77
Moscow 63
Chandler 60
Ashburn 59
Rome 55
The Dalles 55
Pisa 51
Munich 50
Florence 36
Santa Clara 34
Beauharnois 29
Boardman 28
Los Angeles 27
Istanbul 23
London 22
Bologna 20
Genoa 20
Nuremberg 20
Frankfurt am Main 19
Livorno 19
Lucca 19
Lappeenranta 18
Naples 17
Helsinki 14
Chicago 13
New York 13
Amsterdam 12
Assago 12
Brescia 12
Turku 12
Washington 12
Boston 11
Brooklyn 11
São Paulo 11
San Mateo 10
Mumbai 9
Portsmouth 9
Turin 9
Buti 8
Dallas 8
Lahore 8
Ottawa 8
Palermo 8
Seattle 8
Warsaw 8
Belo Horizonte 7
Cascina 7
Dongguan 7
Vienna 7
Zhengzhou 7
Bari 6
Brussels 6
Cambridge 6
Charlotte 6
Düsseldorf 6
Montreal 6
Padova 6
Paris 6
Shenzhen 6
Tokyo 6
Toronto 6
Veglie 6
Zurich 6
Chennai 5
Fremont 5
Johannesburg 5
Lawrence 5
Mexico City 5
Phoenix 5
Reggio Emilia 5
San Francisco 5
Secaucus 5
Stevenage 5
Tashkent 5
Woodbridge 5
Brasília 4
Bucharest 4
Curitiba 4
Erbil 4
Gozzano 4
Gujranwala 4
Islamabad 4
Massa 4
Perugia 4
Rawalpindi 4
Rio de Janeiro 4
Suzhou 4
Venice 4
Verona 4
Viareggio 4
Wilmington 4
Ankara 3
Aversa 3
Cordenons 3
Dhaka 3
El Paso 3
Totale 1.977
Nome #
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 284
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 225
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 188
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 147
Screening the health status of people working in a university 129
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 124
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 119
The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers 111
Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis 110
Eligibility for vericiguat in a real‐world, contemporary heart failure population 109
Role of Imaging in Cardiomyopathies 107
Subclinical cardiac damage in cancer patients before chemotherapy 106
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 102
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction 102
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 95
Valvular heart disease in patients with cardiac amyloidosis 92
Sex-related differences in ventricular remodeling after myocardial infarction 89
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 81
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 80
Sex differences in transthyretin cardiac amyloidosis 73
The triglyceride/HDL cholesterol ratio and TyG index predict coronary atherosclerosis and outcome in the general population 73
RNA-targeting and gene editing therapies for transthyretin amyloidosis 72
Indications of beta-adrenoceptor blockers in Takotsubo syndrome and theoretical reasons to prefer agents with vasodilating activity 72
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 70
Management and treatment of cardiotoxicity due to anticancer drugs: 10 questions and answers 69
Cardiac Amyloidosis: How Its Epidemiology is Changing 69
Bridging Atrial and Ventricular Failure Through Biomarkers 69
Shared and unique characteristics of metabolic syndrome in psychotic disorders: a review 66
Assessing cardiac mechanics through left ventricular haemodynamic forces 65
Pathophysiology of Cardiac Amyloidosis 61
Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin 61
High-sensitivity troponins for outcome prediction in the general population: a systematic review and meta-analysis 60
Tetrameric Transthyretin as a Protective Factor Against Alzheimer’s Disease 60
Pirfenidone as a novel cardiac protective treatment 60
Pathophysiological Rationale and Clinical Evidence for Neurohormonal Modulation in Heart Failure with Preserved Ejection Fraction 59
Heart failure with preserved ejection fraction risk after aortic coarctation surgery: The hidden threat 59
Dissecting the heart failure phenotype through phenomics 57
CRISPR-Cas9 for the Treatment of Transthyretin Cardiac Amyloidosis 55
Identifying reliable biomarkers for pulmonary congestion: Toward a close yet sustainable heart failure follow‐up 53
Insulin‐like growth factor binding protein‐7 in heart failure: The challenge of moving from risk prediction to a biomarker‐guided management 52
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 51
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 51
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 51
The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism 46
Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond 45
Metabolomics to predict heart failure development: A new frontier? 37
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 29
null 29
Current and emerging treatment options for transthyretin amyloid cardiomyopathy 24
Gamma-glutamyltransferase independently predicts mortality and hospitalization for heart failure in cardiac transthyretin amyloidosis 18
Characteristics of patients with suspected cardiac amyloidosis in Tuscany and Umbria: Insights from the cardiac amyloidosis RegistRY (CARRY) 15
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 11
Echocardiographic Estimate of Pulmonary Capillary Wedge Pressure Improves Outcome Prediction in Heart Failure Patients with Reduced and Mildly Reduced Ejection Fraction 4
Transesophageal Echocardiography Before Elective Direct Current Cardioversion in Cardiac Amyloidosis: Too Soon to Discard It? 2
Heart Failure Management in Cardiac Amyloidosis: Towards a Paradigm Shift 2
Totale 4.150
Categoria #
all - tutte 29.569
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.569


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202266 0 0 0 5 7 7 10 17 7 6 2 5
2022/2023367 5 28 10 21 44 40 14 47 109 10 27 12
2023/2024333 13 11 63 36 7 25 27 13 15 26 28 69
2024/20252.806 71 68 134 108 184 154 383 539 286 175 378 326
2025/2026578 441 137 0 0 0 0 0 0 0 0 0 0
Totale 4.150